Evidence map›Paper›PMID 39166032›Full record

ArticleHeliyon2024

Fabrication of Ag-doped BiOF-reduced graphene oxide composites for photocatalytic elimination of organic dyes.

Md Elias, Rowshon Alam, Sebak Sarker, Mohammad Awlad Hossain

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Md EliasDepartment of Chemistry, Jagannath University, Dhaka-1100, Dhaka, Bangladesh.
Rowshon AlamDepartment of Chemistry, Jagannath University, Dhaka-1100, Dhaka, Bangladesh.
Sebak SarkerDepartment of Chemistry, Jagannath University, Dhaka-1100, Dhaka, Bangladesh.
Mohammad Awlad HossainDepartment of Chemistry, Jagannath University, Dhaka-1100, Dhaka, Bangladesh.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bismuth oxyfluoride (BiOF) is an emerging class of material with notable chemical stability, unique layered structure and striking energy band structure. Bi-based semiconductor materials and reduced graphene oxides (rGOs) have attracted considerable attention due to their broad spectrum of potential applications. Herein, we successfully synthesised an efficient photocatalyst comprising BiOF-rGO nanocomposites with embedded Ag nanoparticles using a simple hydrothermal method. The synthesised nanocomposites were characterised through Fourier-transform infrared spectroscopy, X-ray diffraction (XRD), field emission scanning electron microscopy and ultraviolet (UV)-visible spectroscopy. The XRD results indicated the crystalline structures of the BiOF, Ag-doped BiOF and Ag-doped BiOF-rGO composites. Photocatalytic activity assessments focused on the degradation of methylene blue (MB) and methyl orange (MO) dyes under UV-light and sunlight irradiation. The Ag-doped BiOF-rGO composite exhibited significantly enhanced degradation efficiency, achieving 61.81 % and 74.25 % degradation of MB and MO, respectively, after 300 min under UV-light irradiation. On the contrary, pure BiOF demonstrated only 17.63 % and 48.29 % degradation for MB and MO, respectively, under similar conditions. Furthermore, under sunlight irradiation, the Ag-doped BiOF-rGO composite exhibited an MB removal efficiency of 43.87 % after 300 min, whereas pure BiOF showed only 27.47 % under identical conditions. These results underscore the potential of Ag-doped BiOF-rGO composites as highly efficient and adaptable photocatalysts for the photodegradation of organic dyes in industrial wastewater.

Indexed as

BiOFPhotocatalystPhotodegradationReduced graphene oxideSemiconductorSilver

Identifiers

PMID39166032
PMCPMC11333893

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.